146 related articles for article (PubMed ID: 35416325)
21. Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma.
Yang Y; Kelly P; Shaffer AL; Schmitz R; Yoo HM; Liu X; Huang DW; Webster D; Young RM; Nakagawa M; Ceribelli M; Wright GW; Yang Y; Zhao H; Yu X; Xu W; Chan WC; Jaffe ES; Gascoyne RD; Campo E; Rosenwald A; Ott G; Delabie J; Rimsza L; Staudt LM
Cancer Cell; 2016 Apr; 29(4):494-507. PubMed ID: 27070702
[TBL] [Abstract][Full Text] [Related]
22. PTBP1 promotes the growth of breast cancer cells through the PTEN/Akt pathway and autophagy.
Wang X; Li Y; Fan Y; Yu X; Mao X; Jin F
J Cell Physiol; 2018 Nov; 233(11):8930-8939. PubMed ID: 29856478
[TBL] [Abstract][Full Text] [Related]
23. Long noncoding RNA HCG22 suppresses proliferation and metastasis of bladder cancer cells by regulation of PTBP1.
Jiang D; Zhang Y; Yang L; Lu W; Mai L; Guo H; Liu X
J Cell Physiol; 2020 Feb; 235(2):1711-1722. PubMed ID: 31304601
[TBL] [Abstract][Full Text] [Related]
24. PTBP1-mediated regulation of AXL mRNA stability plays a role in lung tumorigenesis.
Cho CY; Chung SY; Lin S; Huang JS; Chen YL; Jiang SS; Cheng LC; Kuo TH; Lay JD; Yang YY; Lai GM; Chuang SE
Sci Rep; 2019 Nov; 9(1):16922. PubMed ID: 31729427
[TBL] [Abstract][Full Text] [Related]
25. p53-targeted lncRNA ST7-AS1 acts as a tumour suppressor by interacting with PTBP1 to suppress the Wnt/β-catenin signalling pathway in glioma.
Sheng J; He X; Yu W; Chen Y; Long Y; Wang K; Zhu S; Liu Q
Cancer Lett; 2021 Apr; 503():54-68. PubMed ID: 33476649
[TBL] [Abstract][Full Text] [Related]
26. Loss of KLHL6 promotes diffuse large B-cell lymphoma growth and survival by stabilizing the mRNA decay factor roquin2.
Choi J; Lee K; Ingvarsdottir K; Bonasio R; Saraf A; Florens L; Washburn MP; Tadros S; Green MR; Busino L
Nat Cell Biol; 2018 May; 20(5):586-596. PubMed ID: 29695787
[TBL] [Abstract][Full Text] [Related]
27. CBR3-AS1 Accelerates the Malignant Proliferation of Gestational Choriocarcinoma Cells by Stabilizing SETD4.
Zhang Y; Zhang H; Zhang X; Liu B
Dis Markers; 2022; 2022():7155525. PubMed ID: 35655916
[TBL] [Abstract][Full Text] [Related]
28. METTL3-modified lncRNA-SNHG8 binds to PTBP1 to regulate ALAS2 expression to increase oxidative stress and promote myocardial infarction.
Tang J; Tang QX; Liu S
Mol Cell Biochem; 2023 Jun; 478(6):1217-1229. PubMed ID: 36282350
[TBL] [Abstract][Full Text] [Related]
29. PTBP1 modulates osteosarcoma chemoresistance to cisplatin by regulating the expression of the copper transporter SLC31A1.
Cheng C; Ding Q; Zhang Z; Wang S; Zhong B; Huang X; Shao Z
J Cell Mol Med; 2020 May; 24(9):5274-5289. PubMed ID: 32207235
[TBL] [Abstract][Full Text] [Related]
30. CX-4945, a Selective Inhibitor of Casein Kinase 2, Synergizes with B Cell Receptor Signaling Inhibitors in Inducing Diffuse Large B Cell Lymphoma Cell Death.
Mandato E; Nunes SC; Zaffino F; Casellato A; Macaccaro P; Tubi LQ; Visentin A; Trentin L; Semenzato G; Piazza F
Curr Cancer Drug Targets; 2018; 18(6):608-616. PubMed ID: 28460620
[TBL] [Abstract][Full Text] [Related]
31. A novel LINC00478 serves as a tumor suppressor in endometrial carcinoma progression.
Feng Y; Dong Y; Rao B; Yu Y; Su W; Zeng J; Zhao E; Chen Y; Fang S; Zhou Y; Lu J; Qiu F
J Cancer Res Clin Oncol; 2023 Nov; 149(16):14927-14940. PubMed ID: 37603104
[TBL] [Abstract][Full Text] [Related]
32. Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens.
Young RM; Wu T; Schmitz R; Dawood M; Xiao W; Phelan JD; Xu W; Menard L; Meffre E; Chan WC; Jaffe ES; Gascoyne RD; Campo E; Rosenwald A; Ott G; Delabie J; Rimsza LM; Staudt LM
Proc Natl Acad Sci U S A; 2015 Nov; 112(44):13447-54. PubMed ID: 26483459
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia induced LUCAT1/PTBP1 axis modulates cancer cell viability and chemotherapy response.
Huan L; Guo T; Wu Y; Xu L; Huang S; Xu Y; Liang L; He X
Mol Cancer; 2020 Jan; 19(1):11. PubMed ID: 31964396
[TBL] [Abstract][Full Text] [Related]
34. Identification of Ezrin-Radixin-Moesin proteins as novel regulators of pathogenic B-cell receptor signaling and tumor growth in diffuse large B-cell lymphoma.
Pore D; Bodo J; Danda A; Yan D; Phillips JG; Lindner D; Hill BT; Smith MR; Hsi ED; Gupta N
Leukemia; 2015 Sep; 29(9):1857-67. PubMed ID: 25801911
[TBL] [Abstract][Full Text] [Related]
35. LncRNA HOXB-AS3 binding to PTBP1 protein regulates lipid metabolism by targeting SREBP1 in endometrioid carcinoma.
Zhou Q; Kong D; Li W; Shi Z; Liu Y; Sun R; Ma X; Qiu C; Liu Z; Hou Y; Jiang J
Life Sci; 2023 May; 320():121512. PubMed ID: 36858312
[TBL] [Abstract][Full Text] [Related]
36. LncRNA SNHG14/miR-5590-3p/ZEB1 positive feedback loop promoted diffuse large B cell lymphoma progression and immune evasion through regulating PD-1/PD-L1 checkpoint.
Zhao L; Liu Y; Zhang J; Liu Y; Qi Q
Cell Death Dis; 2019 Sep; 10(10):731. PubMed ID: 31570691
[TBL] [Abstract][Full Text] [Related]
37. PTBP1 drives c-Myc-dependent gastric cancer progression and stemness.
Ni T; Chu Z; Tao L; Zhao Y; Zhu M; Luo Y; Sunagawa M; Wang H; Liu Y
Br J Cancer; 2023 Apr; 128(6):1005-1018. PubMed ID: 36635500
[TBL] [Abstract][Full Text] [Related]
38. Circular RNA circRHOBTB3 represses metastasis by regulating the HuR-mediated mRNA stability of PTBP1 in colorectal cancer.
Chen J; Wu Y; Luo X; Jin D; Zhou W; Ju Z; Wang D; Meng Q; Wang H; Fu X; Xu J; Song Z
Theranostics; 2021; 11(15):7507-7526. PubMed ID: 34158864
[No Abstract] [Full Text] [Related]
39. Quantitative immunofluorescence reveals the signature of active B-cell receptor signaling in diffuse large B-cell lymphoma.
Bogusz AM; Baxter RH; Currie T; Sinha P; Sohani AR; Kutok JL; Rodig SJ
Clin Cancer Res; 2012 Nov; 18(22):6122-35. PubMed ID: 22966017
[TBL] [Abstract][Full Text] [Related]
40. RNA-binding protein Ptbp1 is essential for BCR-mediated antibody production.
Sasanuma H; Ozawa M; Yoshida N
Int Immunol; 2019 Mar; 31(3):157-166. PubMed ID: 30476084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
